Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children

S. Zanconato, V. Piovan, L. Ghiro, M. Corradi, R. Alinovi, A. Bodini, S. Carraro, G. Piacentini, E. Baraldi (Padova, Verona)

Source: Annual Congress 2002 - Airway inflammation in children
Session: Airway inflammation in children
Session type: Oral Presentation
Number: 2631
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Zanconato, V. Piovan, L. Ghiro, M. Corradi, R. Alinovi, A. Bodini, S. Carraro, G. Piacentini, E. Baraldi (Padova, Verona). Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children. Eur Respir J 2002; 20: Suppl. 38, 2631

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Source: Eur Respir J 2002; 20: 1393-1398
Year: 2002



Leukotrienes in exhaled breath condensate of children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

pH in exhaled breath condensate of patients with inflammatory airway diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003

Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Leukotrienes in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003

Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004

8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Leukotrienes and 8-isoprostane in exhaled breath condensate of children with asymptomatic steroid-naive asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008